Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Saioa Arrieta-Aranzueque
Institutions:
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Centro de Investigación Médica Aplicada
Observed institutions:
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Centro de Investigación Médica Aplicada
ORCID:
0009-0007-5294-1338
Observed ORCID:
0009-0007-5294-1338
OpenAlex ID:
A5134967935
Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer
2026
·
Alvaro Lopez-Janeiro
, José González-Gomariz
, et al.
·
Journal of Clinical Investigation
·
5
PDF
T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody
2026
·
Carlos Luri-Rey
, Inmaculada Rodríguez
, et al.
·
Immunity
·
1
PDF
Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
·
Cancer Research
·
1
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment
2026
·
Elixabet Bolaños
, Lorena Cañas-Zabala
, et al.
·
The Journal of Experimental Medicine
·
1
PDF
Monomethyl-auristatin E-based anti-CD137 (4-1BB) antibody drug conjugates are not suitable tools to deplete activated T lymphocytes
2026
·
Gabriel Gomis
, Saioa Arrieta-Aranzueque
, et al.
·
Immunobiology
·
1
Supplementary Fig. S7 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S3 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S1 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S2 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S5 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S11 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S4 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S10 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S9 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Data from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S8 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Supplementary Fig. S6 from Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
2026
·
Gabriel Gomis
, Claudia Herrero
, et al.
Show more works
View as search
Works count:
17
Citation count:
9
H-index:
1
I10-index:
Year
Topic
Type